Skip to main content
Home News Page 5

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us

https://otc.duke.edu/wp-content/uploads/2023/08/OTC-team-photo-2023-narrow-no-waving.png

Duke Spotlight: Office for Translation & Commercialization Turns Smart Ideas into Reality

At its core, the Office for Translation & Commercialization is designed to help Duke’s creative minds get the most out of their ideas.

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/zhou_pei_HERO2.jpg

Synthetic Antibiotic Could Be Effective Against Drug-Resistant Superbugs

Decades of work by a series of Duke investigators yields new drug, patents and a startup company Valanbio Therapeutics

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/clinetic-logo.png

Clinetic Announces Series A Funding Round Led by Sopris Capital

Clinetic is a medical records Duke start-up founded on technology developed by a team at the Duke Institute for Health Innovation

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/Benner-Study-01@0.25x.png

Newly Identified Lipid in Breast Milk Might Reduce Cerebral Palsy in Infants

Tellus Therapeutics, a neonatal white matter injury therapeutics start-up, was co-founded by Dr. Eric Brenner (Pediatrics, SOM)

Read More

https://otc.duke.edu/wp-content/uploads/2023/08/lily-schoen-at-ELN-event.webp

Exploring Entrepreneurship and Social Impact as a New Venture Fellow

Recent Duke Fuqua graduate Lily Schoen reflects on her experience, including working as a New Venture Fellow with Duke OTC

Read More

https://otc.duke.edu/wp-content/uploads/2023/06/American-Diabetes-Association-2023-Innovation-Challenge.jpeg

Minutia, Oregon Health & Sciences University and Go Pen Win First-Ever American Diabetes Association Innovation Challenge

Minutia is a next generation cell therapy start-up co-founded by cell sensing luminary Professor Tuan Vo-Dinh (BME, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2022/09/Realtime-Robotics.png

Realtime Robotics Funded an Additional $9.5 Million to Meet Increased Demand for Technology that Transforms Manufacturing

Realtime Robotics, a Duke start-up and Duke Capital Partners portfolio company, was founded by Professor Daniel Sorin (ECE, Pratt).

Read More

https://otc.duke.edu/wp-content/uploads/2023/06/bruce-ten63-featured-image.jpg

How a Duke Professor and Two Duke Ph.D.s are Building an AI Drug Discovery Start-Up

Duke Professor Bruce Donald and his former students are combining computer science, structural biology, and an entrepreneurial spirit to design new drugs at Ten63 Therapeutics.

Read More

https://otc.duke.edu/wp-content/uploads/2023/06/solve-acquires-cereius-featured-image.png

Solve Therapeutics, Inc. Acquires Cereius, Inc., a Duke University Spin-Out

Cereius, a Duke start-up co-founded by Professor Michael Zalutsky (Radiology, SOM) and Dr. Kimberly Blackwell (Adjunct Professor, SOM), has been acquired by Solve Therapeutics.

Read More

1 3 4 5 6 7 49